Work

An ECOG Phase II Study of Amonafide in Unresectable or Recurrent Carcinoma of the Head and Neck (PB390)

Year: 1997

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/a:1005823703909

Authors: Andrea N. Leaf, Donna Neuberg, Edward L. Schwartz, Scott Wadler, Paul S. Ritch, Janice P. Dutcher, George L. Adams

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Medical College of Wisconsin, University of Minnesota

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute

Awards: G1422427855, EASTERN COOPERATIVE ONCOLOGY GROUP, G721629745, EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES, ECOG Statistical Office, G92717670

OpenAlex ID: W2398357402

FWCI: 0.419

Cites: 18

Cited by: 5

Related to: 10